在结直肠癌的发展中,miR-155/FOXO3a的亲致癌作用
Dianxiu Wang1, Wei Geng2, Lu Han3
1Department of General Surgery, Sijing Hospital of SongJiang District, Shanghai, 201601, China. wdx1727@163.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|November 13, 2023
概括
微RNA-155 (miR-155) 通过抑制FOXO3a.a.来促进结直肠癌 (CRC) 恶性病变. 抑制miR-155或恢复FOXO3a可能为CRC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 微RNAs (miRNAs) 在CRC中作为生物标志物和治疗点.
- 已知miR-155有助于CRC中辐射抵抗.
研究的目的:
- 阐明miR-155在结直肠癌细胞恶性瘤中的作用和机制.
- 调查miR-155与CRC下游目标之间的监管关系.
主要方法:
- 在CRC组织中分析miR-155表达.
- 功能丧失实验评估miR-155缺乏对CRC细胞行为的影响.
- 使用分子分析识别和验证miR-155目标.
- 救援实验证实了miR-155和FOXO3a.a.之间的功能相互作用.
主要成果:
- 在CRC组织中,miR-155被显著上调.
- miR-155缺乏抑制了CRC细胞的增殖,入侵和迁移.
- miR-155直接准并降低FOXO3a表达的调节.
- 在CRC组织中,FOXO3a的下调,与miR-155.5的反相关.
- 过度表达FOXO3a抑制了CRC细胞的生长和侵入.
- FOXO3a沉默可以逆转miR-155缺乏对CRC细胞的影响.
结论:
- miR-155通过向FOXO3a来促进CRC细胞的增殖,迁移和入侵.
- miR-155/FOXO3a轴代表了结直肠癌的潜在治疗标.
- 这项研究提供了对驱动CRC进展的分子机制的见解.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


